Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | AADAT | Q8N5Z0 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | NOS3 | P29474 | 2/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.34 |
| ▸ | DRD2 | P14416 | 2/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | NSD2 | O96028 | 1/20 | 0.33 |
| ▸ | HK1 | P19367 | 1/20 | 0.33 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19899056 | 0.87 | CHRM4 (0.41) | KIF11AADATNOTUMDRD2CHRM4 | |
| SCHEMBL19899123 | 0.82 | NOS3 (0.38) | AADATMAOAMAOBNOS3TP53 | |
| SCHEMBL28526989 | 0.80 | POLB (0.45) | KIF11NOS3NOS2DRD2HTR7 | |
| SCHEMBL8605029 | 0.76 | ACHE (0.51) | TDP1 | |
| SCHEMBL943506 | 0.76 | ACHE (0.51) | TDP1 | |
| SCHEMBL17768596 | 0.73 | KDM4E (0.36) | TDP1NSD2GABRA1GABRB2 | |
| SCHEMBL28381823 | 0.72 | ACHE (0.42) | NOS3NOS2NOTUMDRD2HTR7 | |
| SCHEMBL29700470 | 0.70 | AADAT (0.41) | KIF11AADATMAOAMAOBNOS3 | |
| SCHEMBL11490469 | 0.70 | POLB (0.50) | NOTUMDRD2CHRM4HTR7GABRA1 | |
| SCHEMBL19899120 | 0.70 | P2RX7 (0.40) | TP53DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3423431-B1 | CARBAMATE DERIVATIVE COMPOUNDS AND THEIR USES | BIO PHARM SOLUTIONS CO LTD (KR) | 2023-11-29 | — | — | EP | disclosed |
| EP-3423431-B1 | CARBAMATE DERIVATIVE COMPOUNDS AND THEIR USES | BIO PHARM SOLUTIONS CO LTD (KR) | 2023-11-29 | — | — | EP | disclosed |
| US-11168052-B2 | Carbamate derivative compounds, processes for preparing them and their uses | BIO-PHARM SOLUTIONS CO., LTD. | 2021-11-09 | — | — | US | disclosed |
| US-11168052-B2 | Carbamate derivative compounds, processes for preparing them and their uses | BIO-PHARM SOLUTIONS CO., LTD. | 2021-11-09 | — | — | US | disclosed |
| CN-109195946-B | Carbamate derivative compound, preparation method and application thereof | 生物药品解决方案有限公司 | 2021-09-07 | — | — | CN | disclosed |
| EP-3423431-A1 | CARBAMATE DERIVATIVE COMPOUNDS, PROCESSES FOR PREPARING THEM AND THEIR USES | Bio-Pharm Solutions Co., Ltd. (KR) | 2019-01-09 | — | — | EP | disclosed |
| US-20180057449-A1 | CARBAMATE DERIVATIVE COMPOUNDS, PROCESSES FOR PREPARING THEM AND THEIR USES | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
| US-20180057449-A1 | CARBAMATE DERIVATIVE COMPOUNDS, PROCESSES FOR PREPARING THEM AND THEIR USES | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
| US-20180057449-A1 | CARBAMATE DERIVATIVE COMPOUNDS, PROCESSES FOR PREPARING THEM AND THEIR USES | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11168052-B2 | Carbamate derivative compounds, processes for preparing them and their uses | ACHE, BCHE, AQP4 | KIF11 2898/4885AADAT 1036/4885MAOA 1692/4885 |
| US-20180057449-A1 | CARBAMATE DERIVATIVE COMPOUNDS, PROCESSES FOR PREPARING THEM AND THEIR USES | ACHE, BCHE, AQP4 | KIF11 2898/4885AADAT 1036/4885MAOA 1692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.